Author
H. Parthasarathy
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2021-2021 · peak 5/yrCo-Author Collaboration Network
10 top collaborators · 37 mutual co-author links5 papers
Recent·Most cited
Regulation of eIF2α Phosphorylation by MAPKs Influences Polysome Stability and Protein Translation
S. Parveen, H. Parthasarathy, D. Vedagiri, D. Gupta, H. G. Nair, K. H. Harshan
This study shows that p38 MAPK and ERK1/2 regulate polysome stability and translation through integrated stress response pathways, with dual inhibition causing significant polysome collapse.
bioRxiv · Aug 30, 2021 · PreprintBiochemistry
SARS-CoV-2 Infection Causes Strong mTORC1 Inhibition and Massive Polysome Collapse
H. Parthasarathy, D. Gupta, D. Tandel, V. Sah, A. H. Siddiqui, A. P. Suresh, K. H. Harshan
This study shows SARS-CoV-2 infection inhibits mTORC1 and causes polysome collapse, but not through eIF2 phosphorylation, and allows viral mRNA translation while suppressing host mRNA translation.
bioRxiv · May 8, 2021 · PreprintMicrobiology
Inactivation of SARS-CoV-2 by β-propiolactone Causes Aggregation of Viral Particles and Loss of Antigenic Potential
D. Gupta, H. Parthasarathy, V. Sah, D. Tandel, D. Vedagiri, S. Reddy, K. H. Harshan
This study examines the effects of β-propiolactone on SARS-CoV-2 inactivation, finding that higher concentrations cause protein loss, antigenic degradation, and virion aggregation.
bioRxiv · Apr 22, 2021Microbiology
Development of Equine Immunoglobulin Fragment F(ab')2 with High Neutralizing Capability against SARS-CoV-2
D. Gupta, F. Ahmed, D. Tandel, H. Parthasarathy, D. Vedagiri, V. Sah, K. M. Bodduluru, S. S. Daga, R. A. Khan, C. Kondiparthi, P. Savari, S. H. Jain, J. S. Daga, S. Reddy, N. Khan, K. H. Harshan
This study develops equine-derived F(ab')2 antibodies with high neutralizing capability against SARS-CoV-2, showing effectiveness against viral variants.
bioRxiv · Mar 9, 2021 · PreprintImmunology